Evatanepag
≥99%
- Product Code: 100497
CAS:
223488-57-1
| Molecular Weight: | 468.57 g./mol | Molecular Formula: | C₂₅H₂₈N₂O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Evatanepag is primarily used in the treatment of pulmonary arterial hypertension (PAH). It functions as a selective prostacyclin receptor agonist, helping to dilate blood vessels and reduce blood pressure in the lungs, thereby improving exercise capacity and delaying disease progression. This makes it a valuable therapeutic option for patients suffering from PAH, particularly those who may not respond well to other treatments. Additionally, its oral administration offers a convenient alternative to more invasive therapies, enhancing patient compliance and quality of life.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿15,390.00 |
+
-
|
| 0.005 | 10-20 days | ฿35,910.00 |
+
-
|
Evatanepag
Evatanepag is primarily used in the treatment of pulmonary arterial hypertension (PAH). It functions as a selective prostacyclin receptor agonist, helping to dilate blood vessels and reduce blood pressure in the lungs, thereby improving exercise capacity and delaying disease progression. This makes it a valuable therapeutic option for patients suffering from PAH, particularly those who may not respond well to other treatments. Additionally, its oral administration offers a convenient alternative to more invasive therapies, enhancing patient compliance and quality of life.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :